(Reuters) – The U.S. Food and Drug Administration website showed on Monday one dose of Novo Nordisk’s weight-loss drug Wegovy is available after being in short supply, while three other doses remained in limited availability due to increased demand.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar)
Brought to you by www.srnnews.com
